What's New in Research Funding

Molecular structuresPage last updated March 20, 2019

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the Medical Sciences Building, Room 2331 to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact dan.harney@utoronto.ca.
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

Recently Received News and Updates
 

March 20, 2019
 

  • The Michael R Freeman Innovation Award: Cardiac and Vascular Collaborative Innovation Competition (in collaboration with the Heart and Stroke/Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), and  the academic/teaching hospitals from the Toronto Central Local Health Integration Network (TCLHIN)). The goal is to spur innovation and collaboration between institutes with the aim of improving quality of care within cardiac and vascular programs. The purpose of the award is to provide seed funding for novel ideas aimed at cardiovascular disease management, emphasizing collaborative research and development at multiple sites within the TCLHIN and initiated by at least one investigator from within the LHIN. Priority will be given to ideas with a pathway toward commercialization within 5 years. Read more.
    Funding Source/Details: 
    – Each of the seven participating sites (HSC, SMH, SHS, SHSC, UHN, UoT TBEP and WCH) will commit funds of $35,000 per site toward associated activities at their site. This will be matched by a $75,000 support by HSRLCE, to provide a potential total award pool of $300K per year. The total potential funding available per year is $300,000 based on multi-site participation in which the HSRLCE will match funds from participating sites with a ratio of 1:3 (HSRLCE: participating site funds).
    – The maximum award per successful proposal is $150,000.
    – Award term will be one year (awardees will have up to two years to spend the money). A second term of funding is possible with re-application and associated competitive review. 
    Deadline for applications: May 15, 2019. Contact: Liz Thuo, Business Manager, HSRLCE Tel: 416-978-2351, hsrl.centre@utoronto.ca.
     
  • Can-GARD (The Canadian Gene Cure Advanced Therapies for Rare Disease): Clinical and Research Fellowship in advanced genomics in paediatric rare disease. Can-GARD project and the Centre for Genetic Medicine (CGM), with support from the Division of Clinical and Metabolic Genetics at The Hospital for Sick Children (SickKids) in Toronto, Ontario, are seeking applications for a Clinical and Research Post-Doctoral Advanced Genomics in Paediatric Rare Disease Fellowship opportunity. Training location: SickKids. Applicants should hold a MD degree or equivalent and completed an accredited residency program. Applicants should be comfortable working in a paediatric medicine environment. Applicants from any specialty or subspecialty are welcome to apply. Deadline has been EXTENDED to March 30, 2019.
     
  • Arthritis Society: Funding Opportunities.
    • Strategic Operating Grants: Strategic Theme I: Improving our understanding of arthritis and finding the cure. Research under this theme will seek to improve our understanding of the causes of arthritis in order to develop new approaches to alleviate the pain, prevent and/or slow the progression of disease, restore joint function, and eventually cure those affected by arthritis. Amount: Up to $120,000 per year for up to 3 years. Deadline for LOIs: April 15, 2019
    • Arthritis Centre Grants. All proposals must support capacity building programs with an aim to increase the number of academic rheumatologists in Canada and/or to support research training in rheumatology. Amount: $15,000 for 1 year, or up to $150,000 for 1 year based on the number of partners.  Deadline for applications: April 15, 2019.
    • Star Career Development Awards. The salary and research funding represents a three year commitment by the Arthritis Society, together with an additional three year commitment by the applicant’s Host Institution. Abstract registration deadline: May 22, 2019; Application deadline: June 26, 2019.
       
  • Canadian Cancer Society (CCS): Impact Grants.  Impact Grants provide funding to support ideas that promote major advancements in research programs, whether at the fundamental discovery stage (such as studies involving model organisms that demonstrate potential for impact) through to applied research (such as patient or population-based proposals). Applications are encouraged from, but not limited to, the areas of biomedical, clinical, health services, and social and population health research. The goal is to provide a mechanism for scientists to adopt innovations and accelerate the application of new knowledge to address problems in cancer research that have the potential for practical application. Amount: Up to $300,000 per year for up to 5 years to a maximum of $1.5 million. Deadline for LOIs: April 17, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • Michael J. Fox Foundation (MJFF): Therapeutic Pipeline Program. the Therapeutic Pipeline Program advances Parkinson's disease therapeutic and intervention development along the pre-clinical and clinical path (i.e., both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches). The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from non-PD indications. Amount: Up to USD $500,000 for pre-clinical or applied technology programs; up to $2 million for clinical programs.
    Visit here for other Open Targeted Funding Programs. 
    Deadline for preliminary proposals: April 19, 2019; Deadline for full proposals by invitation: July 15, 2019.
    INFORMATION WEBINAR: Monday, April 1, 2019 from 12pm-1pm ET. RSVP here.
     
  • Children's Heart Foundation (CHF): Congenital Heart Disease Research Grants. CHF seeks to fund life-saving, life-changing CHD research in clinical cardiology, basic science, population science, and advancement of surgical/interventional techniques. Amount: USD $100,000 for one year. International applicants are eligible. Deadline for applications: June 7, 2019.
     
  • Paris Institute of Advanced Study - Brain, Culture and Society. Applications are welcome from high level international scholars and scientists in the fields of the humanities, social sciences, cognitive sciences, and neurosciences for a research stay of five or ten months during the academic year 2020-2021 within the framework of its “Brain, Culture and Society program”. The Paris IAS gives its research fellows the unique opportunity to work freely on the project of their choice at the interface of neuroscience, the cognitive sciences and the humanities and social sciences. They benefit from the scientific environment of the Institute and receive support for creating contacts with researchers in the academic institutions of Greater Paris. 

March 5, 2019
 

  • Weston Brain Institute: Open Funding Opportunities.
    • Rapid Response Canada. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: Up to $300,000 over 18 months. 
      Parkinson's & Related Diseases: Program INFORMATION WEBINAR: April 3 at 1pm EST. Register hereEXTENDED deadline for LOI's: May 15, 2019 at 2pm EST; Full Proposals deadline: July 16, 2019.
      Alzheimer's & Related Diseases: Deadline for LOI's: April 1, 2019 at 2pm EST; Full Proposals deadline: July 30, 2019.
    • Transformational Research: Canada 2019. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: $200,000 to $1.5M over up to 3 years.
      Deadlines and INFORMATION WEBINARS are the same as the Rapid Response Canada opportunity listed above.
    • Big Ideas: Canada. Projects must have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging, and be led by Canadian Researchers. Amount available: $5M - $20M. Applications are accepted on a rolling basis.
    • Early Phase Clinical Trials: Canada. Projects must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination thereof to help accelerate the development of therapeutics for neurodegenerative diseases of aging. Amount: Up to $1,500,000 per project over up to 4 years. Applications are accepted on a rolling basis.
       
  • Linkage Tool for the Sepsis Research Network Initiative is now available. CIHR has launched a team grant for a sepsis research network. CIHR invites all interested researchers to complete a short survey to join the linkage tool for this competition. 
     
  • CIHR/KRESCENT: Early Career Investigators in Maternal, Reproductive, Child and Youth in Kidney Research. The RFA will be updated with the KRESCENT information in the next week or two. If you are interested in applying to this program, please begin preparing your application and there will soon be an option to pick the KRESCENT pool. The successful applicant in this competition will be able to take advantage of the KRESCENT curriculum and mentorship program. Registration deadline: April 2, 2019; Application deadline: May 14, 2019.
     
  • Workers Compensation Board (WBC) Manitoba: 2019 Research and Workplace Innovation Program. The WCB has created the Research and Workplace Innovation Program (RWIP) to promote and fund scientific research, workplace innovation, training and education projects and knowledge transfer related to prevention of occupational injuries, diseases and return to work of injured or ill workers. RWIP Projects are funded under three (3) streams: 1) Scientific Research, 2) Training and Education, and 3) Workplace Innovation. Amount: Up to $100,000 per year for up to two years. Deadline for Notice of Intents for Scientific Research: March 25, 2019. Application deadline for Scientific Research: May 27, 2019.
    Closing date for other funding streams: June 25, 2019.
     
  • Brain & Behavior Research Foundation: 2019 National Alliance for Research in Schizophrenia and Effective Disorders (NARSAD) Young Investigator Grant. Young Investigator Grants provide each scientist with up to $35,000 per year for two years totaling $70,000 to enable promising investigators to either extend research fellowship training or begin careers as independent research faculty. All research must be relevant to our understanding, treatment and prevention of serious psychiatric disorders, such as: schizophrenia; bipolar; mood and anxiety disorders; and early onset brain and behavior disorders. Application deadline: March 19, 2019.
     
  • Canadian Institute for Military and Veteran Health Research. CIMVHR TPL Research Initiative. The Research Initiative encourages researchers from relevant fields to submit project proposals to compete for access to funding to accelerate research and improve the health and wellbeing of Canadian military, Veterans, and their families. This opportunity has been made possible through the support of True Patriot Love and the True Patriot Love Fund. The True Patriot Love Fund was established in January 2015 for the purposes of supporting research to discover new treatments, establish evidence-based programs, and increase access to programs and treatments dedicated to advancing the health and well-being of Canadian military members, Veterans, and their families. Deadline for proposals: April 12, 2019.
     
  • ADDF (Alzheimer's Drug Discovery Foundation)-Harrington Scholar Program. This program recognizes physicians or scientists who are doing research to develop drugs to prevent, treat and cure Alzheimer’s disease. The award provides funding and drug development support to help bridge the gap between basic discovery and the clinical realm. Up to three ADDF-Harrington Scholar awards are made each year through a competitive selection process. Amount: Up to $600,000 over two years. Deadline for Letters of Intent: April 12, 2019; Full proposal deadline (invitation only): July 19, 2019.
     
  • Alzheimer's Research UK and the Dementia Consortium: Dementia Consortium Funding. This supports research projects that aim to provide validation of targets for the treatment of dementia or explore the tractability of the target for drug discovery. Promising targets are moved towards the clinic through the successful licence of these projects to industrial partners with the ultimate aim of bringing benefit to patients. Projects are collaborative in nature, with involvement from the consortium members in devising the final project plan. Projects are sought that focus on novel molecular targets in neurodegenerative diseases. Scientists at academic institutions worldwide may apply. Grants are typically worth between £100,000 and £250,000 each over two to three years. Up to £500,000 may be awarded in exceptional cases. Deadline for Expressions of Interest: June 26, 2019.
     
  • British Heart Foundation: Big Beat Challenge. The Big Beat Challenge is a global competition that will culminate in a single research award of up to £30 million to an international multi-disciplinary team, which has identified and proposed a transformational solution to a significant problem in heart and circulatory disease. It is a challenge to scientists, clinicians, innovators and entrepreneurs to look beyond incremental gains and accelerate research breakthroughs that could transform lives across the globe. Teams must be highly collaborative, mobilising knowledge, skills and resources from multiple disciplines and… more » sectors. Proposals must seek to address a specific area of unmet need with a clear route to patient benefit that is as comprehensible to the general public as it is to patients, healthcare professionals and researchers. Teams must demonstrate that their project would not be possible without the proposed scale of funding. Deadline for Stage 1 applications: June 14, 2019.
     
  • Action on Hearing Loss: Translational Research Initiative for Hearing (TRIH) Grants. The scope of the Translational Research Initiative for Hearing call varies from year to year. This year, applications can include: 
    Small molecule, gene or cell-based approaches for the treatment of hearing loss or tinnitus. Amount: Up to £100,000 per year for up to three years. Applicants may be from any country. Deadline for Expressions of Interest: April 7, 2019.
     
  • National Center for Responsible Gambling (NCRG): Grants for Research on Gambling Disorders. 
    • Seed Grants. Applicants may request up to USD $30,000 in direct costs plus 15 percent indirect costs for one year. Deadline for applications: August 1, 2019
    • Large Grants: Large Grants support two-year projects. Applicants may request up to USD $75,000 per year in direct costs and up to 15 percent in indirect costs. Deadline for Letters of Intent: June 3, 2019; Applications deadline: September 3, 2019.
       

February 28, 2019
 

  • CIHR Upcoming Webinars:
  • Cannabis Innovation Summit 
    Presented by the University of Toronto together with its affiliated hospital partners and the Toronto Cannabis & Cannabinoid Research Consortium (TC3)
    The Summit will focus on the drug development of cannabis and cannabinoid related therapies and drug delivery mechanisms from discovery to innovation. It will explore various clinical applications and trials around the assessment of the safety and efficacy of cannabis as a medicine and discuss important societal issues as it relates to mental and body health. This event will also bring together scientists, government officials, policy-makers, research funding organizations and industry partners who are interested in research and innovation in this field.  Read the full agenda. 
    Date: Thursday April 4th, 2019
    Time: 8:00am – 2:30pm

    Location: MaRS Auditorium, Lower Concourse, 101 College Street, Toronto
    Please register here for the Cannabis Innovation Summit
    RBC Series with Daniele Piomelli 
     
  • NIH/CIHR Pre-launch Announcement: Concussion Research Funding Opportunity. “Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (CWOW)”. The objective of this initiative is to support research on discovering and/or validating biological measures to be used for assessing, prognosing, and monitoring recovery of adolescents who either clinically present with or are at risk for developing prolonged/persistent concussive symptoms following exposure to repetitive head impacts and/or concussion. These biological measures should then be incorporated into risk stratification algorithms to inform clinical care and patient stratification for future clinical trials. A key component of this FO will be the broad sharing of clinical, neuroimaging, physiological, and biospecimen data to further advance research in the area of persistent concussive symptoms in early and middle adolescent (EMA; ages 11-17 years old) populations. CIHR's investment will be limited to pediatric concussion researchers based in Canada. It is expected that one grant / research team would be funded by CIHR, with a maximum contribution of $250K/year per grant, for up to 5 years. Deadline for applications to both NIH and CIHR: April 10, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.
     
  • The Bill & Melinda Gates Foundation: Global Challenges - Solving Global health & Development Problems for Those Most in Need. 
  • The Foundation for Prader-Willi Research (FPWR): RFA - Brain Imaging Studies in Individuals with PWS. FPWR is interested in proposals that apply cutting-edge functional brain imaging to examine connectivity in individuals with PWS at specific developmental stages or across development. The scope of this RFA is broad, encompassing descriptive studies or focusing on the neurobiological correlates underlying phenotypic abnormalities characteristics of PWS such as hyperphagia and mental health. Amount: Up to $100,000 USD in direct costs for the initial year of support, with the possibility of a second year of funding upon competitive renewal. Deadline for Letters of Intent: March 4, 2019; Deadline for full proposals: May 6, 2019.
     
  • TS Alliance: Research Grants Program - tuberous sclerosis complex. Most TS Alliance research grants support small, focused projects that allow investigators to develop preliminary data to compete for funding from larger organizations such as the National Institutes of Health (NIH).  Other TS Alliance research grants support postdoctoral fellowships to encourage young investigators to engage in TSC research.  Many of these investigators will continue to pursue TSC research when they establish their own independent laboratories. Amount: Up to USD $150,000 over two years. Deadline for Letters of Intent: April 8, 2019. 
     
  • Sanfilippo Children's Foundation: Project Grants.  The Sanfilippo Children's Foundation is currently calling for expressions of interest for 1) Translational Research Grants (up to AUD $500K/year for up to 3 years) and 2) Incubator Grants (up to AUD $90K for 1 year if salary is included in costing, otherwise up to AUD $25K). Deadline for Expressions of Interest: March 25, 2019.
     
  • Alzheimer's Association: International Research Grant Program. 
    Deadline for Letters of Intent: March 3, 2019; Application deadline: April 29, 2019.
    • Research Grant (and Research Grant to Promote Diversity)
    • Research Grant - New to the Field
    • Research Fellowship (and Research Fellowship to Promote Diversity)
    • Clinician Scientist Fellowship (and Clinician Scientist Fellowship to Promote Diversity)
    • Zenith Fellows Award

February 18, 2019
 

  • Consultation: new Canadian Research and Development Classification. A national consultation to inform the development of the new Canadian Research and Development Classification (CRDC) was recently launched by the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC), the Social Sciences and Humanities Research Council (SSHRC), the Canada Foundation for Innovation (CFI) and Statistics Canada.
    The CRDC will improve how research and development activities and investments are classified in Canada, and will allow greater harmonization, integration and coordination among Canada’s granting agencies.
    You are invited to share your views through the online consultation, which is open until March 22, 2019.
     
  • SickKids Foundation: New Investigator Research Grants.  This program provides support to child health researchers early in their careers so that they can compete with more senior investigators for research grants from other funders. Grant recipients may obtain up to three years of support for research in the biomedical, clinical, health systems and services, population and public health sectors. Amount: Up to $100,000 per year for up to 3 years. 
    Deadline for applications: April 22, 2019. 
    Community Conference Grants bring together families with researchers and clinicians for medical presentations, workshops, symposia and family-oriented discussions. The conference helps to ensure families receive access to the most up-to-date information regarding their children's health. The grant will support events which are organized by and/or for families with children with health challenges, including, but not limited to children with acute illness, chronic illness and disabilities. Amount: Up to $5,000 annually. Deadline for applications: May 31 or September 30, 2019.
     
  • Cancer Research Society: Translational Research Partnership Program. The goal of this program is to support collaborative and pivotal translational research projects. Amount: Up to a maximum of $1,500,000 over up to 3 years per project of which up to 50% may come from the Cancer Research Society. Projects must be translational research and may include clinical trial studies, aim the development of a therapeutic and/or novel technologies, and have excellent preliminary data to support the proposed project. There is no deadline associated with this program. Letters of Intent from applicants with high potential projects will be invited to submit an official application for funding, which is then peer-reviewed. 
     
  • Ontario Brain Institute: ONtrepreneurs Program. This program is Canada's single largest award that catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures. Preference will be given towards an applicant who recently graduated (less than 5 years from the last post-graduate fellowship). Amount: $50,000 (per individual) in addition to training opportunities and mentorship to help early-stage entrepreneurs to build and grow neurotech companies. Deadline for applications: April 1, 2019.
     
  • Cystic Fibrosis Foundation: Awards for Gene Editing for Cystic Fibrosis. To bring new technologies to the CF field, investigators without experience in CF research are encouraged to apply. Information about CF resources may be found in the Tools and Resources section.  The deadline for all applications is March 12, 2019. This RFA has four award options: 
  • Simons Foundation Autism Research Initiative: SFARI Summer 2019 Pilot Award. The goal of the Pilot Award is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. To get a better understanding of SFARI’s different RFAs and whether the Pilot Award may be the best mechanism to support your project, please read their blog post “SFARI RFA reboot: Why, what and how". Amount: Up to USD $300,000 over a maximum of 2 years. Deadline for applications: April 18, 2019. 
     
  • The Orphan Disease Center and the Loulou Foundation: 2019 Pilot Grant Program for CDKL5 Deficiency Disorder (CDD). The Pilot Program provides a one‐year grant for USD $150,000.00 (total cost) to support research related to CDKL5 Deficiency Disorder (CDD). The number of awards may vary. See the RFA for priority areas. Deadline for Letters of Interest: March 8, 2019. Full application deadline: April 4, 2019.
     
  • United Mitochondrial Disease Foundation. UMDF Research Grants. The UMDF Trustees have identified training and supporting the mitochondrial disease research community as a priority for the current grant funding cycle. As such, awards will be made across a wide spectrum of career stages - from Postdoctoral Fellows to Young Investigators to Experienced Investigators. The Foundation's goal is to both aid in the development of the next generation of scientists dedicated to mitochondrial disease research as well as stimulating new directions for more senior researchers. Amounts vary per award. Deadline for proposals: March 15, 2019.
     
  • Human Frontiers Science Program Organization: Program and Young Investigator Grants. Teams will receive up to $450,000 per year for the whole team depending on the size of the team. You must initiate an application via the website by March 18th, 2019. Submission of the Letters of Intent deadline: March 28th, 2019.
    • Program Grants are awarded to teams of independent researchers at any stage of their careers. The research team is expected to develop new lines of research through the collaboration. Up to $450,000 per grant per year may be applied for. Applications including independent investigators early in their careers are encouraged.
    • Young Investigators' Grants are awarded to teams of researchers, all of whom are within the first five years after obtaining an independent laboratory (e.g. Assistant Professor, Lecturer or equivalent). Applications for Young Investigators' Grants will be reviewed in competition with each other independently of applications for Program Grants.
       
  • International Essential Tremor Foundation (IETF): Grant Program. The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor. Preference will be given to individuals who do not currently have any R01 support from NIH. Two proposals are being considered this year. Amount: Up to USD $25,000. Deadline for applications: February 28, 2019.
     
  • Ara Parseghian Medical Research Fund (Niemann-Pick Type C (NPC) disease): Research Grants. This funding supports an international research program:
    •To expedite a treatment and cure for NPC disease
    •To promote collaborative research efforts among the world’s leading experts in cholesterol metabolism, cell biology, neurobiology, genetics, pharmacology and other areas of science
    •To study similar and further the cause of other neurodegenerative diseases as well as cholesterol storage disorders
    Most grants are awarded up to USD $100,000 per year, but they are now offering competitive two-year grants as well. Deadline for Letters of Intent: March 1, 2019; Full application deadline: May 1, 2019.
     

  • Stiftelsen Promobilia Foundation: Grants for Research and Development Projects. The Foundation mainly gives support for development of tools for mobility handicapped but has also supported research about the comprehension of reading and writing difficulties. The Foundation has also supported research around diseases that could lead to severe motion problems. The Foundation gives grants in the range of SEK 100,000 - 500,000 (in USD about 10,000 - 100,000). Deadline for applications: March 14, 2019. 
     

February 5, 2019
 

  • 2019 NSERC Collaborative Research and Training Experience (CREATE):  Information Session.  NSERC’s CREATE program awards grants of up to $1.65M over 6 years for the development of innovative training programs that enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce.
    INFORMATION SESSION: Dr. Luis Seco, a former CREATE Committee member will give insights on the program and the application process. The session details are as follows:
    Tuesday February 12th, 2019, 10am – 11:30am
    McMurrich Building, 12 Queen’s Park Cres. West, Room 107.
    Please RSVP by February 8th by sending an email to:  Teresa Trimboli
    Internal deadlines: 
    • March 1, 2019: Internal Deadline to notify Jessica Keating of interest to apply.
    • April 1, 2019: Internal Deadline for completed Letters of Intent (Quota based).
       
  • Mitacs Globalink Research Award - Call for Applications. Up to 200 senior undergraduate and graduate student, as well as postdoctoral fellows from the university can participate in research exchanges through the Globalinks Research Award pathway. Faculty at U of T and an international university from a partner country will jointly supervise research projects. In addition, up to 80 students and postdoctoral fellows from international universities will come to Canada to conduct research at U of T. The funding for this international research mobility will allow students and researchers to build on their professional and academic networks, to refine their research skills in new environments and gain global fluency.
    Award amount: $6,000 Canadian for 12-24 week long research projects*
    Application deadline: 3 months prior to student arriving at host university
    Eligible participants: undergraduate and graduate Students, and postdoctoral fellows in all disciplines
    Application process: https://learningabroad.utoronto.ca/funding/gra/
    Contact: mahvish.wesley@utoronto.ca
     
  • AGE-WELL, Strategic Investment Program (SIP): Accelerator Funding. This funding program supports innovative post-discovery projects focused on the commercialization and/or knowledge mobilization of solutions (e.g. technologies, services or policies) aligned with AGE-WELL’s mission and vision. Amount: Up to $40,000 over 12 months. The program will also provide strategic mentorship and training opportunities from the AGE-WELL network and its partners in addition to financial support. Further details here. Deadline for Letters of Intent: March 1, 2019.
     
  • CIHR Team Grant - ERA-Net PerMed: Personalized Medicine: Multidisciplinary Research towards Implementation. This funding opportunity will support projects relevant to the following research areas, as described on the IC PerMed International Consortium website. Proposals are expected to include research on ethical, legal and socio-economic implications, including health economics and regulation, and/or research on optimisation of health care systems.
    Deadline for Pre-Proposal to ERA PerMed: March 7, 2019
    Full Proposal to ERA PerMed and Abbreviated Application to CIHR (201906ENP): June 17, 2019

     
  • Ontario Institute for Cancer Research: Cancer Therapeutics Innovation Pipeline.  This call for Letters of Intent (LOI) is for Late Accelerator projects. Focus on screening, using validated primary and secondary assays and to deliver confirmed Hit molecules against a defined target. Amount: Up to $250,000 per year for a maximum of two years. 
    LOI deadline: February 26, 2019; Response to LOI applicants: March 13, 2019
    Full application deadline: April 16, 2019
     
  • Cancer Research Society: 2019 Scholarships for the Next Generation of Scientists. This initiative aims at supporting future generations of Canadian researchers. The Scholarship is broken down into two parts, and extends over a period of 3 years, with no possibility for renewal. Deadline for submissions: April 26, 2019.
    • Part 1: Postdoctoral Salary Award -  1 year -  $50,000 (with a possibility of extending this award for a maximum period of 6 months)
    • Part 2: Operating Grant  -   2 years - $120,000 ($60,000/year)
       
  • Canadian Liver Foundation: Operating Grants. Operating Grants provide funding of up to $60,000 per year for a maximum of two years to hepatobiliary research investigators to pursue major research projects. As the CLF’s most senior award, it is offered to investigators with primary interest in hepatobiliary research who hold academic appointments in Canadian universities or affiliated institutions. Both clinical investigators and basic scientists will be considered. One operating grant may be awarded to a researcher in Canada whose research project is related to liver cancer, and another related to liver transplant. Deadline for applications: March 31, 2019.
     
  • The Ontario HIV Treatment Network (OHTN), Endgame Funding Program: Community-Based Research and Evaluation  (CBR&E) Awards. The objective of the CBR & E Funding is to assist communities by supporting the production and discovery of knowledge through community-based research; and the use of evidence to drive programming through participatory program evaluation. Amount: $25,000 - $50,000 for one year. Application deadlines: March 1, June 7, September 6 and December 6, 2019.
    OHTN's Strategic Plan to 2026: HIV Endgame.
     
  • Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF): Research Grant Program. The Foundation is interested in funding research across the spectrum of basic and clinical science, but highest priority is for studies that have the potential to impact prevention, diagnosis, risk-stratification, or treatment of these diseases within three years. Preference will be given to New Investigators who propose a project that will contribute toward their professional development in bone marrow failure disease research. Amount: Up to USD $60,000 for two years. Deadline for Letters of Intent: February 15, 2019; Full application deadline: March 30, 2019.
     
  • Lupus Research Alliance: Distinguished Innovator Awards in Lupus. This Award provides outstanding scientists with substantial support to conduct novel research -- into the fundamental causes of systemic lupus erythematosus -- that can provide new directions towards a cure. The Lupus Research Alliance welcomes novel, hypothesis - or discovery - driven proposals in human and/or animal-model based lupus research. Amount: Up to USD $250,000 per year for up to four years. Deadline for Letters of Intent: March 15, 2019; Full application deadline: June 26, 2019.
     
  • Kenneth Rainin Foundation: Innovator Awards (in Inflammatory Bowel Disease). The Innovator Awards program provides grants for research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources, such as the National Institutes of Health (NIH). If an applicant is submitting a clinical research proposal, the Foundation encourages the applicant to include basic scientific methodologies to examine the underlying mechanisms of the proposed intervention/treatment. Amount: Up to USD $200,000. Deadline Letters of Inquiry: March 15, 2019; Deadline for full proposals: May 31, 2019.
     
  • International OCD Foundation.
    • Young Investigator Awards.  Research projects must investigate topics in the field of OCD and related disorders (OCD, including pediatric OCD; PANS/PANDAS; hoarding disorder; body dysmorphic disorder). Amount: Up to USD $50,000. Deadline for proposals: February 28, 2019.
    • Breakthrough and Innovator Awards (NEW). Eligible research projects must investigate topics in the field of OCD, with a focus on finding a cure for OCD. Note: this may include prevention (i.e., keeping OCD from taking hold), and treatment (i.e., once symptoms begin, can treatment reduce them as close as possible to zero). Innovator Awards - two awards of up to USD $300,000 each; Breakthrough Award - one award of up to USD $500,000. Deadline for proposals: February 28, 2019.
       

 

January 24, 2019
 

  • CIHR Project Grants - Spring 2019.  The Project Grant program will support a diverse portfolio of health-related research and knowledge translation projects at any stage, from discovery to application, including commercialization, and there will be a specific funding envelope to support new/early career investigators within the overall competition budget. Additional funds will also be made available through CIHR Institutes Priority Announcements to support Project Grant applications in specific research areas. 
    • More information specific to University of Toronto applicants, including Tips & Checklist documents for both Registration and Application submissions, is also available on the Research and Innovation website.
    • CIHR’s Learning For Applicants page provide an overview of the competition as well as a detailed tour of the application process and requirements.
    • CIHR informational webinars with question-and-answer portions will be held between January 23rd and February 27th. Full information on dates & times, as well as the opportunity to register for a webinar in advance, is available on CIHR’s webinars page.
    • Deadline for mandatory registration: February 6, 2019; Application deadline: March 6, 2019.
       
  • Genome Canada: Genomic Applications Partnership Program (GAPP) Round 15 & 16. Precision Health Initiative - Rare Diseases: Clinical Implementation Projects.  Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. In order to initiate this ambitious program, Genome Canada is encouraging the submission of projects to the GAPP. For more details, please see here. The GAPP funds public-private research collaborations focused on downstream research and development (R&D) projects that address real world opportunities and challenges defined by "Receptor" organizations such as industry, government, or not-for-profit entities. These organizations should be committed to commercializing or implementing the outcomes of the project. Applicants interested in applying are encouraged to contact Helen Petropoulos at Ontario Genomics (OG). For information on the application process, please visit the GAPP homepage, or the UofT funding opportunity
    Deadlines for Expressions of Interest (EOIs):
    • Round 15: Draft EOI is due to RSO and OG on Feb 19, 2019; Final EOIs are due to RSO April 1st via MRA to meet OG's deadline of April 8, 2019 
    • Round 16: Draft EOI is due to RSO and OG on May 20, 2019; Final EOIs are due to RSO July 2nd via MRA to meet OG's deadline of July 9, 2019 
       
  • CIHR Mental Wellness in Public Safety Team Grants. CIHR is launching this funding opportunity, to support the development of new research evidence and tools needed to address existing and emerging gaps in post-traumatic stress injuries (PTSI) as it relates to public safety personnel (PSP) in Canada. In alignment with the objectives and the research and strategic priorities of this funding opportunity, applicants are asked to integrate interdisciplinary, open science, and knowledge translation perspectives into their research. Additionally, applicants must integrate sex as a biological variable and/or gender as a social determinant of health. Deadline for Letter of Intent: March 19, 2019; Full application deadline: November 5, 2019.
     
  • REMINDER - Bloorview Research Institute: 2019 Pursuit Award. This prestigious award recognizes outstanding achievements in childhood disability research by PhD students across the globe. Every year, the Pursuit Award receives applications worldwide that are forward-thinking, innovative, and challenge the borders of childhood disability research. Eligibility: Current PhD students (no more than six months away from defence) and postdoctoral trainees/recent graduates (within one year of receiving their PhD) who have made significant contributions in applied or clinical childhood disability research. Any applied or clinical research specifically linked to childhood disability is eligible for consideration. Up to three monetary prizes are awarded and finalists may be eligible for a prestigious post-doctoral fellowship at the Bloorview Research Institute. View the Pursuits Submissions Call 2019. Deadline for applications: February 4, 2019 at 5pm EST.
     
  • Kidney Foundation of Canada (KFOC), ASF, Pedersen Family: Alport Syndrome Research Funding. Funding will be provided for basic science or clinical research on Alport Syndrome. These funds may be used as seed funding for the testing of initial hypotheses and the collection of preliminary data leading to successful long-term funding by NIH, CIHR, or other major funding institutions around the world. Early stage investigators are encouraged to apply. It is anticipated that two research projects will be selected for funding, totaling $100,000 each, over a one- to two-year timeframe. Deadline for applications: February 8, 2019. 
     
  • Physiotherapy Foundation of Canada: OrthoCanada Research Award in Neck and Back Rehabilitation and Core Stability. The award is seed funding for mainly pilot or feasibility projects. The award is for $20,000, jointly funded by OrthoCanada and the Physiotherapy Foundation of Canada (PFC). The principal investigator must be a member of the Canadian Physiotherapy Association. Deadline for applications: February 24, 2019.
     
  • Simons Foundation: Novel Outcome Measures in ASD Request for Applications. Grants awarded through this RFA will support the development and validation of clinically relevant outcome measures that will sensitively and reliably distinguish treatment effects from placebo response on the core symptoms of ASD (i.e., impairment in social communication and social interaction; restricted/repetitive behaviors, interests and activities; and sensory symptoms). The Foundation expects to fund several awards through this mechanism. The maximum budget is $300,000 USD per year, including indirect costs, for up to three years. Deadline for Notice of Intent: February 15, 2019; Application deadline: March 1, 2019.
     

 

January 15, 2019
 

  • Project Management Research Courses - UofT, Division of the Vice-President Research and Innovation (VPRI) and the School of Continuing Studies:  Project management - tailored for research - is an important skill that can reduce risk, delineate key project deliverables and increase the likelihood of research project success. This winter, the School of Continuing Studies is offering two courses in this area. Tuition Assistance: Please check the University’s web page for information on Educational Assistance Programs for Faculty and Staff regarding financial assistance for course tuition. 
    • 3382 Project Management for Research. This course was designed for faculty researchers, staff scientists, post-doctoral fellows, research coordinators and those interested in a path to management and research leadership. Information and registration can be found here for the Winter course starting January 15, 2019. The course will be in-class over 12 weeks. Each participant will have the opportunity to use their own research project in course exercises and assignments.
    • 3590 Six Simple Tools for Managing Research. This one-day seminar will be held March 1, 2019. It will be lead by Dr. Alison Paprica (PMP), Principal of Research Project Management, who does extensive consulting and training for the research sector. This interactive one-day workshop will provide practical tools to participants who will create their own planning documents during the workshop. Information and registration can be found here.
       
  • JLABS (Johnson & Johnson Innovation): QuickFire Challenge - Reimagining Respiratory Protection. JLABS is calling on innovators to revolutionize respiratory protection, to submit novel ideas to better protect against the inhalation of harmful infectious agents. Is there a household item that could transform into a lifesaving face mask during an emergency? Could new textiles or wearable technologies be incorporated into face masks to improve performance? Up to two innovators will be awarded up to $100,000 in grant funding, access to the JLABS ecosystem, and support in developing their ideas from BARDA, to support health security products and technologies in biotechnology, life science research, and medical innovations as they navigate research, development, and regulatory pathways. Deadline for applications: February 15, 2019.
     
  • NSERC Discovery Frontiers: Antimicrobial Resistance (AMR) in the Environment.  The objective this program on AMR is to support research that will integrate disciplines in new ways and provide new strategies and solutions at the forefront of this significant scientific challenge. Areas of importance include, but are not limited to: environmental sources and fate of antibiotic resistant microbes/genes, resistance ecology, resistance evolution, microbial community impacts, ecosystem impacts, impacts of AMR organisms on the environment, animal role as vectors, animal health risks, and mitigation options for further environmental AMR increase. Amount: Up to $1M per year for four years. Please contact jessica.keating@utoronto.ca with your intention to apply.
    UofT internal deadline for editorial review (LOI): February 6, 2019
    UofT Internal deadline for administrative review (LOI): February 21, 2019
    Sponsor deadline: March 1, 2019.

     
  • The Banting & Best Diabetes Centre:  Postdoctoral Fellowships. The BBDC will be awarding a number of postdoctoral fellowships to candidates at the post-PhD or post-MD degree stages.  The one-year fellowships normally commencing on July 1, 2019 (and no later than September 1, 2019) are for full-time research training in diabetes.  To be eligible, the candidate's proposed supervisor must be conducting diabetes research and must hold a faculty appointment with the University of Toronto at the level of Assistant, Associate, or Full Professor.  The proposed supervisor must be employed by the University of Toronto or a University of Toronto-affiliated institution, and must be a registered member of the BBDC at the time of application submission. Deadline for applications: February 26, 2019 at 4pm.
     
  • CIHR Joint Canada-Israel Health Research Program. The fifth call of this program supports biomedical sciences with special emphasis on new frontiers in metabolism in health and disease. Clinical Trials will NOT be funded through this funding opportunity. However, the use of randomization in basic biomedical research studies is accepted. The Program will support world-class research teams co-led by Canadian and Israeli investigators. The teams will be expected to integrate researchers from low- and middle-income countries to further their scientific capacity. Registration deadline: January 29, 2019; MRA deadline for UofT applicants: February 19, 2019; CIHR deadline in ResearchNet: February 26, 2019.
     
  • Autism Speaks: Funding Opportunities. 
    • Predoctoral Fellowships provides highly qualified candidates with exceptional research training opportunities broadly related to the study of autism spectrum disorder. Deadline for LOIs: February 27, 2019.
    • Postdoctoral Fellowships supports well-qualified postdoctoral scientists pursuing training in autism. Deadline for LOIs: February 27, 2019.
    • Adult Transition Research Grants aim to establish evidence-based scalable practices leading to improved postsecondary employment, education, community living and other key outcomes relevant to adolescents and young adults with ASD. Deadline for LOIs: March 13, 2019.
    • Database Analysis Grants invite novel grant applications to increase our basic understanding of autism — from genetics to behavior — by analyzing important databases generated by Autism Speaks: the Autism Genetics Research Exchange (AGRE) and/or MSSNG (a whole genome sequencing resource). Co-analysis of Autism Speaks datasets with other data is encouraged, along with proposals from early career investigators or investigators new to the field. Up to $100,000 for one year. Deadline for LOIs: March 6, 2019.
       
  • Epilepsy Foundation: New Therapy Commercialization Grant and Epilepsy Seal of Innovation Award. The Program seeks to advance the development of new therapies including but not limited to medicines, biologics or devices. All proposals must demonstrate a clear path from the lab to the patient and are evaluated with consideration for their potential value to patients, likelihood of successful development including regulatory approval and the timeframe of development. The Program also encourages 1:1 matching grants to academic and commercial entities to support the commercialization of novel approaches to the treatment of epilepsy. Preference will be given to proposals that already have a commercial partner engaged to assist with development, and to proposals that have committed or matched funding from a sponsoring institution, commercial partner or other third party source. Amount: Up to USD $350,000 for a maximum of two years. Deadline for Letters of Intent: January 28, 2019; Deadline for full proposals: April 1, 2019.
     
  • Jeffrey Modell Foundation: Translational Research Grants - (Primary Immunodeficiency). Grants with the following focus will be strongly considered for awards: 
    1. Novel PI defects 
    2. Innovativeness in early diagnosis 
    3. Treatment advances to a cure 
    4. Impact on patient health (i.e. how a patient will benefit) 
    5. Reach of the proposed project (i.e. how many patients might benefit) 
     Applications submitted by investigators with vast expertise in Primary Immunodeficiency, as well as young investigators with robust scientific merit will all be considered. All international and U.S. applicants are eligible. Upper amount: Up to USD $250,000 over a two-year period. Deadline for applications: February 15, 2019.
     
  • Prostate Cancer Foundation: 2019 Young Investigator Awards. Research proposals submitted in consideration for this award should, if successful, provide high impact to the field. “Small-step” or incremental proposals are usually non-competitive. Highly innovative basic science programs will be carefully considered, but priority will be given to “bench to bedside” translational research proposals with the potential to deliver near term benefit to patients. Amount: USD $75,000 per year for three years. Deadline for applications: March 18, 2019 at 3pm EST.
     
  • Cancer Research Institute: CFI Irvington Postdoctoral Fellowship Program. The CRI Irvington Fellowship furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists. CRI accepts applications from qualified young scientists at leading universities and research centers around the world who wish to receive training in fundamental immunology or tumor immunology. The Institute is seeking hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer. Amount: USD $175,500 over three years. Deadline for applications: April 1, 2019.
     
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

January 9, 2019
 

  • New Frontiers in Research Fund - Exploration: Updates and Resources. Reminder about completing the NOI in order to apply at the Full Proposal stage: The NOI is a mandatory requirement and must be submitted by the NOI deadline of 8 pm EST January 11th, 2019.  Only those who submit an NOI on the Convergence system by the deadline will be able to complete a Full Proposal. 
    The Full Proposal remains under development and still on track to be available on January 14th, 2019.  Program staff indicated during the Webinars earlier this week that the short timelines of this call were being taken into account in the design of the Full Proposal format.
  • UPDATES: AGE-WELL Core Research Program (2020-2025) Call for Proposals - Multiple Revisions. Please note that there will now be three years of available funding through the Open Core Research Program Request for Proposals instead of the planned five. Milestones, deliverables, and budget should reflect a three-year project timeline highlighting what will be accomplished with AGE-WELL funds; however, applications outlining work initially planned for five years may still include the broader project scope. AGE-WELL will work with teams to position them for success through other funding sources for years 4-5. Letters of support from partners that reflect a five-year commitment do not need to be revised. Successful projects will be asked to update their partner commitments within the Catalyst Phase (April 2019 – March 2020). NEW DEADLINES: UofT internal deadline: January 15, 2019; Sponsor deadline: January 22, 2019.
     
  • Banting & Best Diabetes Centre (BBDC): Postdoctoral Fellowships: 2019/2020. The fellowships offered by the BBDC are in-training awards for individuals who hold (or are expecting to complete) a doctoral degree (PhD) or medical degree (MD). The objective of these awards is to attract and foster young investigators to initiate and/or continue research training in the field of diabetes. The one-year fellowships are to be used for full-time diabetes research training at the University of Toronto or one of its affiliated institutions. These awards become tenable July 1, 2019 (and no later than September 1, 2019). Deadline for applications: February 26, 2019 at 4pm.
     
  • Weston Brain Institute: Open Funding Opportunities.
    • Rapid Response Canada. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: Up to $300,000 over 18 months. 
      Parkinson's & Related Diseases: Program INFORMATION WEBINAR: January 31 at 1pm EST. Register here. Deadline for LOI's: March 13, 2019 at 2pm EST; Full Proposals deadline: July 16, 2019.
      Alzheimer's & Related Diseases: Program INFORMATION WEBINAR: February 27 at 1pm EST. Register here. Deadline for LOI's: April 1, 2019 at 2pm EST; Full Proposals deadline: July 30, 2019.
    • Transformational Research: Canada 2019. Funding for transformative, novel, high-risk, high-reward translational research projects on neurodegenerative diseases of aging. Amount: $200,000 to $1.5M over up to 3 years.
      Deadlines and INFORMATION WEBINARS are the same as the Rapid Response Canada opportunity listed above.
    • Big Ideas: Canada. Projects must have a significant and sustained impact on translational research to accelerate the development of therapeutics for neurodegenerative diseases of aging, and be led by Canadian Researchers. Amount available: $5M - $20M. Applications are accepted on a rolling basis.
    • Early Phase Clinical Trials: Canada. Projects must involve the development of either a therapeutic, a tool, select complementary approaches, or a combination thereof to help accelerate the development of therapeutics for neurodegenerative diseases of aging. Amount: Up to $1,500,000 per project over up to 4 years. Applications are accepted on a rolling basis.
       
  • Alzheimer's Drug Discovery Foundation (ADDF): Funding Opportunities.  The 2019 deadlines for LOIs are January 18; April 12, July 19, or October 11, 2019.
    • Program to Accelerate Clinical Trials (PACT). This RFP funds early-stage clinical trials through phase 2 for novel drug candidates, proof-of-concept trials in patients for repurposed/repositioned drugs, and regulatory studies for IND/CTA preclinical packages and drug manufacturing for later stage trials. Average amount: Up to USD $5M.
    • Neuroimaging and CSF Biomarker Development. This RFP supports the development and validation of neuroimaging and CSF biomarkers to enhance clinical trials for Alzheimer's disease, related dementias, and cognitive aging. Average amount: USD $150,000-$600,000.
    • Prevention Beyond the Pipeline. This RFP supports comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline. Amount: USD $50,000-$100,000 for epidemiological analyses; USD Up to $3 million for clinical trials.
    • Drug Discovery. This RFP supports programs advancing lead molecules to clinical candidate selection or building preclinical evidence in relevant animal models for repurposed/repositioned drugs. Average amount: USD $150,000-$600,000.
       
  • British Heart Foundation: Big Beat Challenge. The Big Beat Challenge will bring together world-leading researchers and innovators to identify and solve any of the biggest problems in heart and circulatory disease. This initiative will push the international research community to identify a real-world challenge, significant unmet need, or opportunity for game-changing innovation in heart and circulatory science or medicine. The Big Beat Challenge is open to any and all areas of heart and circulatory research, and welcomes applications based anywhere in the world. The Big Beat Challenge is a single research funding award of £30,000,000. Depending on the quality of the applications received, more than one award may be funded in this round of funding. Call will open early January. Deadline for Stage 1 applications: Mid-2019.
     
  • Lupus Research Alliance.
    • Novel Research Grants provide early stage support for highly innovative approaches to major challenges in lupus research. Special emphasis is placed on lupus studies exploring fundamental mechanisms, novel targets and pathways, novel technologies, and interdisciplinary approaches. Early-career investigators are encouraged to apply through this mechanism. Up to USD $150,000 per year for up to two years. Deadline for applications: February 1, 2019.
    • Target Identification in Lupus Grants support highly meritorious research focused on the identification and scientific and/or clinical investigation of molecular pathways and therapeutic targets that will lead to new therapies or improved management for patients with lupus. Up to USD $200,000 per year for up to three years. Deadline for applications: February 1, 2019.
       
  • The Klarman Family Foundation: Eating Disorders Research Grants Program. The fundamental aim of this grants program is to understand the biology underlying the psychiatric disease anorexia nervosa, with the goal of accelerating progress toward prevention and treatment. Grants are funded to academic researchers for 1 – 3 year projects to research the biology of this disease, and the questions of how and why it develops and persists. Approaches that incorporate neurobiology with an up-to-date understanding of the symptoms and dysfunction associated with anorexia nervosa are encouraged. Amount: Up to USD $150,000 for a 1 year pilot study, and up to USD $250,000 per year  for 1 – 3 year research projects (inclusive of up to 10% indirect costs). Deadline for applications: February 14, 2019 at 1pm EST.
     
  • Leukemia Research Foundation: Hollis Brownstein New Investigator Grant 2019. This program funds highly promising scientists in this critical research niche. This program provides a one year grant of USD $100,000 to allow innovative scientists to act on their ideas, and try new procedures and experiments that will lead to significant breakthroughs. Deadline for Letters of Intent: February 1, 2019.
     
  • Organization for Autism Research (OAR): Applied Research Competition. Through this competition, OAR intends to promote evidence-based practices delivered from research in the following areas: 
    The analysis, evaluation, or comparison of current models of assessment, intervention, or systems of service delivery, including policy analysis 
    - Applied aspects of educational, behavioral, or social/communicative intervention 
    - Effective intervention across the lifespan for individuals considered to be severely impacted by autism 
    - Adult issues such as continuing education, employment, residential supports, sexuality instruction, quality-of-life determinants, and "later intervention" 
    - Issues related to family support, social and community integration, assessment and intervention with challenging behavior, and the use of technology in support of learners with ASD 
    Upper amount: USD $40,000. Deadline for preliminary proposals: March 25, 2019.
     
  • Desmoid Tumor Research Foundation (DTRF): Research Grants. The DTRF funds research that will advance the current scientific knowledge about desmoid tumors, moving toward the development of new treatment options and the ultimate goal of a cure. Research proposals with additional sources of funding support are particularly desirable. Researchers must be willing to collaborate with other scientists and institutions with similar interests. Upper amount: USD $65,000. Deadline for applications: April 1, 2019.
     
  • Muscular Dystrophy Association (MDA): Translational Research. MVP funds projects from proof-of-principle studies through phase 2 trials. For-profit entities are required to contribute funds that match or exceed MDA's contribution. MDA will negotiate return on investment. Projects funded by MVP are milestone-driven projects, with funds released according to the completion of pre-agreed upon sections of the project. MVP will consider funding projects up to USD $1M, depending on the stage of research. MVP is interested in partnering with applicants to accelerate research on projects with strong institutional support, and in general MVP funds should constitute less than 50% of the total project budget. Deadline for Letters of Intent: March 1, 2019; June 1, 2019; and September 1, 2019.
  • NIH Various Opportunities. Visit here to see the National Institutes of Health's recently released requests for applications and program announcementsFor more information on NIH application and the submission process, please visit the University's Research Funding Opportunities found here.

 

Back to Top